This report contains market size and forecasts of Pazopanib in global, including the following market information:
Global Pazopanib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pazopanib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pazopanib companies in 2021 (%)
The global Pazopanib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
200mg Tables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pazopanib include Novartis and GlaxoSmithKline etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pazopanib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pazopanib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pazopanib Market Segment Percentages, by Type, 2021 (%)
200mg Tables
400mg Tables
Global Pazopanib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pazopanib Market Segment Percentages, by Application, 2021 (%)
Renal Cell Carcinoma
Soft Tissue Sarcoma
Other
Global Pazopanib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pazopanib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pazopanib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pazopanib revenues share in global market, 2021 (%)
Key companies Pazopanib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pazopanib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GlaxoSmithKline